Qtas

📍 Garching, Germany🗓 Founded 2025👥 17 employees💰 Last funded Dec 2025
Research🌐 qtas.com
Website LinkedIn
At Qtas, we’re building a quantum-enabled liquid biopsy platform designed for pharma and translational research workflows. Our technology enables automated isolation of rare circulating tumor cells directly from whole blood—unlocking rapid, high-quality downstream analysis such as sequencing, molecular profiling, and functional assays. Qtas helps pharma teams generate earlier, more actionable insights to accelerate therapy development and optimization.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2025
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Switzerland
1
Frequently asked questions
Who invested in Qtas?
Qtas has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Qtas last raise funding?
The most recent investment in Qtas recorded on gritt.io was in December 2025.
When was Qtas founded?
Qtas was founded in 2025.
What industry is Qtas in?
Qtas operates in Research. Find similar Research investors on gritt.io.
Where is Qtas based?
Qtas is headquartered in Garching, Germany.